AMIX

Autonomix Medical Inc

• Reuters·5d ago

  Autonomix Medical to present pancreatic cancer pain study at SIR 2026 meeting

• Reuters·5d ago

  Autonomix study shows long-term pain relief in pancreatic cancer, set for SIR podium

• Benzinga·03/20 21:05

  12 Health Care Stocks Moving In Friday's After-Market Session

• Reuters·03/11 12:41

  Autonomix Medical CEO Brad Hauser to Present at LSI USA ’26

• Benzinga·03/09 19:59

  Autonomix Medical Has Received A Notice Of Allowance For A U.S. Patent Titled "DEVICES, SYSTEMS, AND METHODS FOR DIAGNOSIS AND TREATMENT OF OVERACTIVE BLADDER".

• Reuters·03/05 13:45

  Autonomix Medical Selected for CRT 2026 Best Innovation Competition Oral Presentation

• TipRanks·03/04 13:46

  Autonomix to present clinical study on Nerve Neurolysis at CRT 2026

• Reuters·03/04 13:40

  Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting

• Benzinga·02/27 21:05

  12 Health Care Stocks Moving In Friday's After-Market Session

• Reuters·02/25 13:31

  Autonomix Medical CEO Brad Hauser Highlights Publication Strategy and Scientific Validation

• Reuters·02/25 13:30

  AUTONOMIX MEDICAL ANNOUNCES RELEASE OF NEW CEO CORNER SEGMENT HIGHLIGHTING PUBLICATION STRATEGY AND SCIENTIFIC VALIDATION

• TipRanks·02/19 13:48

  Autonomix selected to present new long-term pain mitigation data at SSO 2026

• Reuters·02/19 13:30

  Autonomix Medical to Present Long-Term Pancreatic Cancer Pain Data at SSO 2026 Annual Meeting

• Dow Jones·02/17 20:12

  Autonomix Medical Is Maintained at Buy by Maxim Group

• Dow Jones·02/17 20:12

  Autonomix Medical Price Target Cut to $2.00/Share From $5.00 by Maxim Group